264
Views
6
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study

, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 3531-3538 | Published online: 31 Dec 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.